Quest diagnostics reports second quarter 2025 financial results; raises guidance for full year 2025

Second quarter revenues of $2.76 billion, up 15.2% from 2024 second quarter reported diluted earnings per share ("eps") of $2.47, up 21.7% from 2024; and adjusted diluted eps of $2.62, up 11.5% from 2024 year-to-date cash provided by operations of $858 million, up 67.1% from 2024 full year 2025 reported diluted eps now expected to be between $8.60 and $8.80; and adjusted diluted eps is expected to be between $9.63 and $9.83 secaucus, n.j. , july 22, 2025 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leading provider of diagnostic information services, today announced financial results for the second quarter ended june 30, 2025.
DGX Ratings Summary
DGX Quant Ranking